Clinical Trials Directory

Trials / Conditions / Gastric Cancers

Gastric Cancers

17 registered clinical trials studyying Gastric Cancers — 9 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patie
NCT07219238
GE HealthcarePhase 2 / Phase 3
RecruitingQL1706 Combined With SOX Used in Theperioperative Treatment
NCT06766305
Xiangdong ChengPhase 1 / Phase 2
RecruitingCorrelation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer
NCT07003334
Nanfang Hospital, Southern Medical University—
Active Not RecruitingThe Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
NCT06856382
Dong Peng—
RecruitingRobotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
NCT06895447
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2
Active Not RecruitingThe Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
NCT06854146
Dong Peng—
RecruitingAI-Assisted Non-Contrast CT for Multi-Cancer Screening
NCT06632886
Guo ShiWeiN/A
Active Not RecruitingPredictive Value of Air Pollution and Metabolomics for Gastric Cancer.
NCT06641700
Dong Peng—
Active Not RecruitingValidation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy
NCT06807372
Jichao Qin—
RecruitingAnalysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy
NCT06728878
Jichao Qin—
RecruitingRaman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
NCT06822413
Second Affiliated Hospital, School of Medicine, Zhejiang University—
RecruitingBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
NCT04421820
Bold Therapeutics, Inc.Phase 1 / Phase 2
CompletedEvaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC
NCT06706466
Chang-Ming Huang, Prof.—
Active Not RecruitingA Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
NCT02734004
AstraZenecaPhase 1 / Phase 2
Active Not RecruitingPredictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients
NCT06606912
First Affiliated Hospital of Chongqing Medical University—
CompletedPrediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
NCT06686966
First Affiliated Hospital of Chongqing Medical University—
RecruitingTissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Can
NCT01416714
University of Chicago—